Pramipexole use and the risk of pneumonia

BACKGROUND: Patients with Parkinson's disease have an elevated risk of pneumonia and randomized trials suggest that this risk may be increased with the dopamine agonist pramipexole. It is uncertain whether pramipexole or other dopamine agonists increase the risk of pneumonia. METHODS: We used t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ernst, Pierre, Renoux, Christel, Dell'Aniello, Sophie, Suissa, Samy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522019/
https://www.ncbi.nlm.nih.gov/pubmed/23020246
http://dx.doi.org/10.1186/1471-2377-12-113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522019/
https://www.ncbi.nlm.nih.gov/pubmed/23020246
http://dx.doi.org/10.1186/1471-2377-12-113

Ejemplares similares